These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6682567)
1. Improved lactate extraction in dogs with coronary artery ligation following administration of a thromboxane synthetase inhibitor. Eddy LJ; Oei HH; Glenn TM Res Commun Chem Pathol Pharmacol; 1983 Jan; 39(1):87-97. PubMed ID: 6682567 [TBL] [Abstract][Full Text] [Related]
2. Interference with the prostaglandin system as a therapeutical concept to protect the myocardium during ischemic stress: experimental studies with inhibition of thromboxane synthesis. Korb H; Hoeft A; Borowski A; de Vivie ER; Hellige G Thorac Cardiovasc Surg; 1988 Aug; 36(4):187-93. PubMed ID: 3187978 [TBL] [Abstract][Full Text] [Related]
3. Effect of a novel thromboxane A2 synthetase inhibitor on ischemia-induced mitochondrial dysfunction in canine hearts. Ogawa T; Hieda N; Sugiyama S; Toki Y; Ito T; Ogawa K; Satake T; Ozawa T Arzneimittelforschung; 1988 Feb; 38(2):228-30. PubMed ID: 3370069 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of thromboxane synthetase by the imidazole derivative 3-(1H-imidazol-1-yl-methyl)-2-methyl-1H-indole-1-propanoic acid as a novel therapeutic approach to experimental myocardial ischemia. Korb H; Hoeft A; Wober W; Wolpers HG; Hellige G Arzneimittelforschung; 1986 Jul; 36(7):1040-4. PubMed ID: 3768069 [TBL] [Abstract][Full Text] [Related]
5. Correlation between myocardial blood flow and tissue succinate during acute ischemia. Kato K; Matsubara T; Sakamoto N Nagoya J Med Sci; 1994 Mar; 57(1-4):43-50. PubMed ID: 7898561 [TBL] [Abstract][Full Text] [Related]
6. CGS-12970, a thromboxane synthetase inhibitor, limits ischemic damage following coronary artery occlusion. Hock CE; Lefer AM Res Commun Chem Pathol Pharmacol; 1986 Jun; 52(3):285-94. PubMed ID: 3755540 [TBL] [Abstract][Full Text] [Related]
7. A canine model of acute coronary artery stenosis: effects of deliberate hypotension. Hickey RF; Verrier ED; Baer RW; Vlahakes GJ; Fein G; Hoffman JI Anesthesiology; 1983 Sep; 59(3):226-36. PubMed ID: 6881588 [TBL] [Abstract][Full Text] [Related]
8. Effects of the selective thromboxane synthetase inhibitor, dazoxiben, on cyclic flow variations in stenosed canine coronary arteries. Bush LR; Campbell WB; Tilton GD; Buja LM; Willerson JT Trans Assoc Am Physicians; 1983; 96():103-12. PubMed ID: 6687298 [No Abstract] [Full Text] [Related]
9. Dichloroacetate attenuates myocardial acidosis and metabolic changes induced by partial occlusion of the coronary artery in dogs. Sakai K; Ichihara K; Nasa Y; Kamigaki M; Abiko Y Arch Int Pharmacodyn Ther; 1990; 307():92-108. PubMed ID: 2095718 [TBL] [Abstract][Full Text] [Related]
10. A method for evaluating antianginal drugs in experimental animals: assessment of myocardial ischemia by myocardial pH. Abiko Y; Ichihara K; Sakai K; Sashida H; Ishibashi T Methods Find Exp Clin Pharmacol; 1986 May; 8(5):271-8. PubMed ID: 2873274 [TBL] [Abstract][Full Text] [Related]
11. The effect of beta-adrenoceptor blockade and of thromboxane synthetase inhibition, alone and in combination, on arrhythmias resulting from myocardial ischemia. Wainwright CL; Parratt JR Adv Myocardiol; 1985; 6():573-84. PubMed ID: 4039460 [TBL] [Abstract][Full Text] [Related]
12. Effects of a thromboxane A2 synthetase inhibitor on ventricular fibrillation threshold during coronary artery occlusion and reperfusion. Toda I; Nozaki A; Kawakubo K; Murakawa Y; Inoue H; Yoshimoto N; Sugimoto T Jpn Heart J; 1990 Jan; 31(1):87-97. PubMed ID: 2335849 [TBL] [Abstract][Full Text] [Related]
13. The effect of nitroglycerin, dipyridamole, and propranolol on glycogen metabolism during coronary artery ligation in dogs. Ichihara K; Abiko Y Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():531-5. PubMed ID: 829648 [TBL] [Abstract][Full Text] [Related]
14. Effect of the thromboxane synthetase inhibitor UK-37,248 (dazoxiben) upon platelet aggregation, coronary artery thrombosis and vascular reactivity. Schumacher WA; Lucchesi BR J Pharmacol Exp Ther; 1983 Dec; 227(3):790-6. PubMed ID: 6418881 [TBL] [Abstract][Full Text] [Related]
15. Inhibition by nitroglycerin of canine platelet aggregation and cyclic flow reductions in stenosed coronary arteries. Tanaka T; Morishima Y; Watanabe K; Takahashi M; Shibano T Methods Find Exp Clin Pharmacol; 1995 Dec; 17(10):693-700. PubMed ID: 9053590 [TBL] [Abstract][Full Text] [Related]
16. Effect of niludipine on ischemic myocardial metabolism in the dog. Ichihara K; Ichihara M; Abiko Y Arzneimittelforschung; 1980; 30(5):785-91. PubMed ID: 7190421 [TBL] [Abstract][Full Text] [Related]
17. Effect of verapamil and nifedipine on ischemic myocardial metabolism in dogs. Ichihara K; Ichihara M; Abiko Y Arzneimittelforschung; 1979; 29(10):1539-44. PubMed ID: 583218 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of a thromboxane synthetase inhibitor in circumflex coronary artery occlusion and reperfusion. Huddleston CB; Lupinetti FM; Clanton J; Collins J; Oates JA; Hammon JW Curr Surg; 1983; 40(3):211-5. PubMed ID: 6683615 [No Abstract] [Full Text] [Related]
19. [Protective effect of thromboxane A2 synthetase inhibitor (trapidil) on acutely-induced cerebral ischemia]. Katayama Y; Shimizu J; Memezawa H; Minamisawa H; Suzuki S; Sugimoto S; Terashi A No To Shinkei; 1986 Oct; 38(10):925-31. PubMed ID: 3790357 [TBL] [Abstract][Full Text] [Related]
20. Lack of involvement of thromboxane A2 in postischemic recovery of stunned canine myocardium. Farber NE; Pieper GM; Gross GJ Circulation; 1988 Aug; 78(2):450-61. PubMed ID: 3396181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]